COMPANY
GenoGenix LLC
GenoGenix LLC: warning letter recipient, recalling firm for Retatrutide, Semaglutide, Tirzepatide, BPC-157, GHK-Cu, Glutathione, Oxytocin, Sermorelin, Tesamorelin, as stated by public registers.
Also written as: GenoGenix LLC.
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| Retatrutide | Compounding Pharmacy/Adulterated Drug Products, 2026-01-20 Regulator FDA warning letters |
|---|---|
| Semaglutide | Compounding Pharmacy/Adulterated Drug Products, 2026-01-20 Regulator FDA warning letters |
| Tirzepatide | Compounding Pharmacy/Adulterated Drug Products, 2026-01-20 Regulator FDA warning letters |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| BPC-157 | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
|---|---|
| GHK-Cu | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| Glutathione | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| Oxytocin | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| Retatrutide | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| Semaglutide | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| Sermorelin | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| Tesamorelin | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| Tirzepatide | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.